Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis

Sanderson A. Cauduro, Kevin G. Moder, Harvinder S. Luthra, James B. Seward

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective. To assess the safety and efficacy of echocardiographically guided pericardiocentesis for patients with rheumatoid arthritis (RA) and hemodynamically significant pericardial effusion. Methods. We identified 16 patients with RA who underwent 18 echocardiographically guided pericardiocentesis procedures at our institution over a 20-year period. Clinical and laboratory characteristics of the patients, response to treatment, complications, and need for future pericardial surgery were abstracted from the echocardiography database. Results. Ten patients were men and 6 were women (mean age, 62 yrs; range, 36-75 yrs). On average, patients were diagnosed with RA 11 years before pericardial disease developed. Twelve of 15 patients were seropositive for rheumatoid factor, 10 patients had radiographic evidence of erosions, and 7 patients had rheumatoid nodules. Cardiac tamponade was present in 11 of the 18 cases. Mean volume drained on the first pericardiocentesis was 504 ± 264 ml (range 120-1000 ml). The fluid was an exudate with a mean protein concentration of 5 g/dl (range 3.3-51.1 g/dl). All cultures and cytologic findings were negative for bacteria and neoplastic cells. No serious complications resulted from echocardiographically guided pericardiocentesis. For 11 patients, a catheter was placed for intermittent drainage over an average of 3 days. Seven patients ultimately required a more definitive surgical procedure. Conclusion. Echocardiographically guided pericardiocentesis is a safe and effective treatment for this uncommon but serious complication of RA.

Original languageEnglish (US)
Pages (from-to)2173-2177
Number of pages5
JournalJournal of Rheumatology
Volume33
Issue number11
StatePublished - Nov 2006

Fingerprint

Pericardiocentesis
Pericardial Effusion
Rheumatoid Arthritis
Therapeutics
Rheumatoid Nodule
Cardiac Tamponade
Rheumatoid Factor
Exudates and Transudates
Echocardiography
Drainage
Catheters
Databases

Keywords

  • Echocardiography
  • Pericardiocentesis
  • Pericarditis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis. / Cauduro, Sanderson A.; Moder, Kevin G.; Luthra, Harvinder S.; Seward, James B.

In: Journal of Rheumatology, Vol. 33, No. 11, 11.2006, p. 2173-2177.

Research output: Contribution to journalArticle

Cauduro, Sanderson A. ; Moder, Kevin G. ; Luthra, Harvinder S. ; Seward, James B. / Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis. In: Journal of Rheumatology. 2006 ; Vol. 33, No. 11. pp. 2173-2177.
@article{63f7eb09067f4afda9a81ff780a020f2,
title = "Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis",
abstract = "Objective. To assess the safety and efficacy of echocardiographically guided pericardiocentesis for patients with rheumatoid arthritis (RA) and hemodynamically significant pericardial effusion. Methods. We identified 16 patients with RA who underwent 18 echocardiographically guided pericardiocentesis procedures at our institution over a 20-year period. Clinical and laboratory characteristics of the patients, response to treatment, complications, and need for future pericardial surgery were abstracted from the echocardiography database. Results. Ten patients were men and 6 were women (mean age, 62 yrs; range, 36-75 yrs). On average, patients were diagnosed with RA 11 years before pericardial disease developed. Twelve of 15 patients were seropositive for rheumatoid factor, 10 patients had radiographic evidence of erosions, and 7 patients had rheumatoid nodules. Cardiac tamponade was present in 11 of the 18 cases. Mean volume drained on the first pericardiocentesis was 504 ± 264 ml (range 120-1000 ml). The fluid was an exudate with a mean protein concentration of 5 g/dl (range 3.3-51.1 g/dl). All cultures and cytologic findings were negative for bacteria and neoplastic cells. No serious complications resulted from echocardiographically guided pericardiocentesis. For 11 patients, a catheter was placed for intermittent drainage over an average of 3 days. Seven patients ultimately required a more definitive surgical procedure. Conclusion. Echocardiographically guided pericardiocentesis is a safe and effective treatment for this uncommon but serious complication of RA.",
keywords = "Echocardiography, Pericardiocentesis, Pericarditis, Rheumatoid arthritis",
author = "Cauduro, {Sanderson A.} and Moder, {Kevin G.} and Luthra, {Harvinder S.} and Seward, {James B.}",
year = "2006",
month = "11",
language = "English (US)",
volume = "33",
pages = "2173--2177",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "11",

}

TY - JOUR

T1 - Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis

AU - Cauduro, Sanderson A.

AU - Moder, Kevin G.

AU - Luthra, Harvinder S.

AU - Seward, James B.

PY - 2006/11

Y1 - 2006/11

N2 - Objective. To assess the safety and efficacy of echocardiographically guided pericardiocentesis for patients with rheumatoid arthritis (RA) and hemodynamically significant pericardial effusion. Methods. We identified 16 patients with RA who underwent 18 echocardiographically guided pericardiocentesis procedures at our institution over a 20-year period. Clinical and laboratory characteristics of the patients, response to treatment, complications, and need for future pericardial surgery were abstracted from the echocardiography database. Results. Ten patients were men and 6 were women (mean age, 62 yrs; range, 36-75 yrs). On average, patients were diagnosed with RA 11 years before pericardial disease developed. Twelve of 15 patients were seropositive for rheumatoid factor, 10 patients had radiographic evidence of erosions, and 7 patients had rheumatoid nodules. Cardiac tamponade was present in 11 of the 18 cases. Mean volume drained on the first pericardiocentesis was 504 ± 264 ml (range 120-1000 ml). The fluid was an exudate with a mean protein concentration of 5 g/dl (range 3.3-51.1 g/dl). All cultures and cytologic findings were negative for bacteria and neoplastic cells. No serious complications resulted from echocardiographically guided pericardiocentesis. For 11 patients, a catheter was placed for intermittent drainage over an average of 3 days. Seven patients ultimately required a more definitive surgical procedure. Conclusion. Echocardiographically guided pericardiocentesis is a safe and effective treatment for this uncommon but serious complication of RA.

AB - Objective. To assess the safety and efficacy of echocardiographically guided pericardiocentesis for patients with rheumatoid arthritis (RA) and hemodynamically significant pericardial effusion. Methods. We identified 16 patients with RA who underwent 18 echocardiographically guided pericardiocentesis procedures at our institution over a 20-year period. Clinical and laboratory characteristics of the patients, response to treatment, complications, and need for future pericardial surgery were abstracted from the echocardiography database. Results. Ten patients were men and 6 were women (mean age, 62 yrs; range, 36-75 yrs). On average, patients were diagnosed with RA 11 years before pericardial disease developed. Twelve of 15 patients were seropositive for rheumatoid factor, 10 patients had radiographic evidence of erosions, and 7 patients had rheumatoid nodules. Cardiac tamponade was present in 11 of the 18 cases. Mean volume drained on the first pericardiocentesis was 504 ± 264 ml (range 120-1000 ml). The fluid was an exudate with a mean protein concentration of 5 g/dl (range 3.3-51.1 g/dl). All cultures and cytologic findings were negative for bacteria and neoplastic cells. No serious complications resulted from echocardiographically guided pericardiocentesis. For 11 patients, a catheter was placed for intermittent drainage over an average of 3 days. Seven patients ultimately required a more definitive surgical procedure. Conclusion. Echocardiographically guided pericardiocentesis is a safe and effective treatment for this uncommon but serious complication of RA.

KW - Echocardiography

KW - Pericardiocentesis

KW - Pericarditis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=33750989080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750989080&partnerID=8YFLogxK

M3 - Article

C2 - 17086604

AN - SCOPUS:33750989080

VL - 33

SP - 2173

EP - 2177

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 11

ER -